Electrolyte quintet: Calcium (Q34750096)

4 August 2017

1 reference

title

Electrolyte quintet: Calcium (English)

1 reference

4 August 2017

D A Bushinsky

1

1 reference

PubMed ID

9690425

4 August 2017

R D Monk

series ordinal

2

1 reference

PubMed ID

9690425

4 August 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

4 August 2017

1 reference

4 August 2017

352

1 reference

4 August 2017

9124

1 reference

4 August 2017

306-311

1 reference

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Calcium-ion-sensing cell-surface receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Management of acute hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Hypercalcemia of malignancy in the palliative care patient: a treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

The contribution of acidosis to renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Medical management of asymptomatic primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Estrogens and progestins in the management of primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Drug therapy of hypercalcemia due to malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Use of bisphosphonates in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

Hypocalcemic emergencies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2912331-5

7 January 2021

10.1016/S0140-6736(97)12331-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

9690425